Biotech Stock News: (GALE) (AMGN) (ARIA) (BXLT)

Galena Biopharma (NASDAQ:GALE) On Monday August 24, 2015 Shares of Galena Biopharma were able to close the day up 11% after announcing an update for its phase 3 trial known as the “PRESENT” trial. The company announced that the independent data monitoring committee — IDMC — concluded that it would be able to reduce the … Read more

Biotech Stock News (NVS) (AVEO) (OMER) (VTL)

Aveo Oncology (NASDAQ:AVEO) & Novartis (NYSE:NVS) On August 17, 2015 shares of Aveo reached as high as 126% in one day after the company announced a partnership with Novartis. Under the terms of the agreement Novartis will make an upfront payment to Aveo for $15 million. This is in exchange for a partnership for both … Read more

Biotech Stock News (INO) (AZN) (IMUC) (AAVL) (REGN)

Inovio Pharmaceuticals (NASDAQ:INO) On August 10, 2015 shares of Inovio were up about 25% after the company announced a partnership deal with a big pharmaceutical company known as AstraZeneca (NYSE:AZN). Although one key thing to note here is that this deal is being established with MedImmune specifically, but it is the research and development arm for … Read more

Biotech Stock News (BIIB) (LLY) (AVXL) (ITEK) (XOMA)

Biogen (NASDAQ:BIIB) On July 22, 2015 shares of Biogen fell about 4% after reporting mixed results for its Alzheimer’s drug known as aducanumab. This phase 1b trial was known as the “PRIME” trial and patients were randomized into two different dosing groups. One group of patients either took 1 mg, 3 mg , 6 mg … Read more

Biotech Stock News (RXII)(REGN)(SNY)(ESPR)(ISIS)(BIIB)

Rxi Pharmaceuticals (NASDAQ:RXII) On June 9, 2015 shares of Rxi Pharmaceuticals went up 6% after the company reported that two new key patents were given to the company for use with their self-delivering sd-rxRNA technology platform. The new patents establish a few new details that enhance upon the company’s prospects: First the new patent is … Read more

Biotech Stock News (AZN) (AMGN) (NVS) (LLY) (HRTX) (MRK)

AstraZeneca (NYSE:AZN) & Amgen (NASDAQ:AMGN) On May 26, 2015 both AstraZeneca and Amgen announced that it would end a partnership established back in 2012 for a psoriasis drug collaboration. This collaboration established in 2012 allowed Astrazeneca to work on five antibody compounds from Amgen’s anti-inflammation drug pipeline. Amgen received an upfront payment of at least … Read more

Biotech Stock News (AMPE) (ALNY) (AERI)

Ampio Pharmaceuticals (NASDAQ:AMPE) On April 20, 2015 Shares of Ampio Pharmaceuticals fell about 66% after the company reported that it had failed to meet the primary endpoint of a phase 3 clinical trial, known as the STRIDE trial. This trial recruited 320 patients with Osteoarthritis and patients were randomized into two different groups. One group … Read more

Biotech Stock News (ARWR)(AMGN)(ATHX)(PFE)

Arrowhead Research Corp (NASDAQ:ARWR) On April 13, 2015 Arrowhead announced that it was given the go-ahead by the FDA to begin treating patients in the phase 2b Hepatitis B study.  The drug compound being used in the study is known as ARC-520 which is an RNAi drug. RNAi stands for RNA interference and these types … Read more

Biotech Stock News (RXII) (MRK) (BMY) (CNAT) (ICPT)

Rxi Pharmaceuticals Corp (NASDAQ: RXII) Rxi Pharmaceuticals last week on March 23, 2015 presented at the 73rd Annual Academy of Dermatology in which the company reported  positive progress on clinical trial updates for its dermatology programs. The clinical trial with RXI-109-1301 phase 2a enrolled patients to be tested for hypertrophic scars on the abdomen only. … Read more